Lupin inks pact with Exeltis to promote Solosec drug in US

Lupin inks pact with Exeltis to promote Solosec drug in US

AgenciesUpdated: Thursday, January 27, 2022, 09:53 PM IST
article-image
As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products. |

Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women.

As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products.

Solosec is indicated for the treatment of bacterial vaginosis in adult women and trichomoniasis in adults, a common non-viral, curable sexually transmitted infection in the US.

''This partnership will expand the reach of Solosec, allowing more healthcare providers to be aware of its benefits, and increase access for adult women suffering with bacterial vaginosis and adults with trichomoniasis,'' stated Lupin CEO Vinita Gupta.

(With inputs from PTI)

RECENT STORIES

World Economic Forum 2026 Davos: MMRDA Signs USD 26 Billion MoUs In AI And Sustainable Industry On...
World Economic Forum 2026 Davos: MMRDA Signs USD 26 Billion MoUs In AI And Sustainable Industry On...
RCB Sale: Serum Institute CEO Adar Poonawalla Confirms Bid To Purchase 2025 IPL Champion Team
RCB Sale: Serum Institute CEO Adar Poonawalla Confirms Bid To Purchase 2025 IPL Champion Team
Union Budget 2026: Job Creation And Export Support Must Be Top Priorities, Says FICCI Industry...
Union Budget 2026: Job Creation And Export Support Must Be Top Priorities, Says FICCI Industry...
Union Budget 2026: Exporters Seek Tax Incentives, Import Duty Rationalisation To Boost Growth
Union Budget 2026: Exporters Seek Tax Incentives, Import Duty Rationalisation To Boost Growth
Union Budget 2026: NAREDCO Seeks Industry Status For Real Estate, Higher Home Loan Interest...
Union Budget 2026: NAREDCO Seeks Industry Status For Real Estate, Higher Home Loan Interest...